Advertisement

Keywords

Breast Cancer Sentinel Lymph Node Sentinel Lymph Node Biopsy Node Group Imprint Cytology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham DC, Jones RC, Jones SE et al (1996) Evaluation of locally advanced breast cancer by magnetic resonance imaging. Cancer 78:91–100CrossRefPubMedGoogle Scholar
  2. Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL (1993) Evaluation of breast masses and axillary lymph-nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 187:743–750PubMedGoogle Scholar
  3. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL, Shenk RR (1997) Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 203:323–327PubMedGoogle Scholar
  4. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nocosia S, Clark R, Cantor A, Reintgen DS (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822CrossRefPubMedGoogle Scholar
  5. Allgayer B, Lukas P, Loos W, Mühlbauer K (1991) Die Treffsicherheit der KST-Diagnostik für die Früherkennung des Mammacarcinoms bei mammographisch und klinisch unklaren Fällen. Röntgenpraxis 44:368–371PubMedGoogle Scholar
  6. Altmannsberger M, Osborn M, Schauer A, Weber K (1981) Antibodies to different intermediate filament proteins. Cell type-specific markers on paraffin-embedded human tissues. Lab Invest 45:427–434Google Scholar
  7. Apostolikas N, Petraki C, Agnantis AG (1988) The reliability of histologically negative axillary lymph-nodes in breast cancer. Pathol Res Pract 184:35–38PubMedGoogle Scholar
  8. Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R (2003) Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cell in vivo. Mol Cancer Res 1(3):165–175PubMedGoogle Scholar
  9. Attiyeh FF, Jensen M, Huvos AG, Fracchia A (1977) Axillary micrometastases and macrometastases in carcinoma of the breast. Surg Gynecol Obstet 144(6):839–842PubMedGoogle Scholar
  10. Avril N, Dose J, Jänicke F, Ziegler S, Romer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M (1996) Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glu-cose. J Natl Cancer Inst 88:1204–1209PubMedGoogle Scholar
  11. Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, Weber W, Ziegler S, Graeff H, Schwaiger M (2000) Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 18:3495–3502PubMedGoogle Scholar
  12. Bender H, Kirst J, Palmedo H, Schomburg A, Wagner U, Ruhlmann J, Biersack HJ (1997) Value of 18-fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res 17:1687–1692PubMedGoogle Scholar
  13. Berry N, Jones D, Marshall R, Smallwood J, Taylor I (1988) Comparison of the detection of breast carcinoma metastases by routine histological diagnosis and by immunohistochemical staining. Eur Surg Res 20:225–232PubMedGoogle Scholar
  14. Black RB, Roberts M, Stewart HJ, Prescott R, Cant EL, Sumerling MD, Smith A, Forrest AP (1980) The search for occult metastases in breast cancer: does it add to established staging method? Aust NZ J Surg 50(6):574–579Google Scholar
  15. Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bartoli C, Coopmans de Yoldi G, Zucali R, Rilke F (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of 3 cm or more. J Natl Cancer Inst 82:1539–1544PubMedGoogle Scholar
  16. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS (1998) Limitations of specific reverse transcriptase polymerase chain reaction markers in the detection of metastases in the lymph node and blood of breast cancer patients. J Clin Oncol 16:2632–2640PubMedGoogle Scholar
  17. Botti C, Vici P, Lopez M, Santo AF, Cognetti F, Cavaliere R (1995) Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large sized operable carcinoma of the breast. J Am Coll Surg 188:202–208Google Scholar
  18. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH, Farley DR, Heller R, Conant E, Orel SG, Lawton TH, Fraker DL, Czerniecki BJ (2000) Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88:2540–2545CrossRefGoogle Scholar
  19. Buada LD, Murakami J, Murayama S, Hasgiguchi N, Sakai SH, Masuda K, Toyoshima S, Kuroki S, Ohno SH (1996) Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200:639–646PubMedGoogle Scholar
  20. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E (1986) The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 54(4):631–636PubMedGoogle Scholar
  21. Byrne J, Waldron R, McAvinchey D, Dervan P (1987) The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases. Eur J Surg Oncol 13(5):409–411PubMedGoogle Scholar
  22. Byrne J, Horgan P, England SS, Callaghan J, Given HF (1992) A preliminary report on the usefulness of monoclonal antibodies to CA 15–3 and MCA in the detection of micrometastases in axillary lymph-nodes draining primary breast cancer. Eur J Surg 28:658–660Google Scholar
  23. Chadh M, Axelrod D (1997) Is axillary dissection always indicated in invasive breast cancer? Oncology (Huntingt) 11:1463–1468PubMedGoogle Scholar
  24. Chen Z-L, Wen D-L, Coulson WF, Giuliano AE, Cochran AJ (1991) Occult metastases in the axillary lymph-nodes of patients with breast cancer node negative by clinical and histological examination and conventional histology. Dis Markers 9(5):239–248PubMedGoogle Scholar
  25. Chobotova K, Spyropoulou I, Carver J, Manek S, Heath JK, Gullick WJ, Barlow DH, Sargent IL, Mardon HJ (2002) Heparin-binding epidermal growth factor and its receptor ErbB4 mediate implantation of the human blastocyst. Mech Dev 119(2):137–144CrossRefPubMedGoogle Scholar
  26. Clayton F, Hopkins CL (1993) Pathologic correlates of prognosis in lymph node positive breast carcinomas. Cancer 71(5):1780–1790PubMedGoogle Scholar
  27. Cooney BS, Orel SG, Schnall MD, Troupin RH (1994) Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging. Am J Roentgenol 162:1318–1320Google Scholar
  28. Cox CE, Bass SS, Ku NN, Berman C, Shons AR, Yeatman TJ, Reintgen DS (1998 a) Sentinel lymphadenectomy: a safe answer to less axillary surgery? Recent Results Cancer Res 152:170–179PubMedGoogle Scholar
  29. Cox CE, Pendas S, Cos JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998b) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–653CrossRefPubMedGoogle Scholar
  30. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E (1998) Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 39:4–8PubMedGoogle Scholar
  31. Crossin JA, Johnson AC, Stewart PB, Turner WW Jr (1998) Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 64:666–668, 669PubMedGoogle Scholar
  32. Cunningham JD, Weiss SE, Ahmed S, Bratton JM, Bleiweiss IJ, Tartter PI, Brower ST (1998) The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Invest 16:80–86PubMedGoogle Scholar
  33. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, Orel SG, Berlin J, Helsabeck C, Fraker DL, Reynolds C (1999) Immunohistochemistry with pancyto-keratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85(1):198–203CrossRefGoogle Scholar
  34. Dabelow A (1957) Die Milchdrüse. Handbuch der mikroskopischen Anatomie, Haut und Sinnesorgane, vol 3, part 3. Springer, Berlin HeidelbergGoogle Scholar
  35. Dewar JA, Sarrazin D, Benhamou E, Petit JY, Benhamou S, Arriagada R, Fontaine F, Castaigne D, Contesso G (1987) Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institute Gustave Roussy. Int J Radiat Oncol Biol Phys 13:475PubMedGoogle Scholar
  36. Dowlatshahi K, Fan M, Snider HC, Habib FA (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–1197CrossRefPubMedGoogle Scholar
  37. Earp HS 3rd, Calvo BF, Sartor CI (2003) The EGF receptor family — multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4. Trans Am Clin Climatol Assoc 114:315–333PubMedGoogle Scholar
  38. Elson CE, Kulfe D, Johnson WW (1993) Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. Anal Quant Cytol Histol 15(3):171–178PubMedGoogle Scholar
  39. Feig SA (1988) Decreased breast cancer mortality through mammographic screening: results of clinical trials. Radiology 167:659–665PubMedGoogle Scholar
  40. Fischer U (2000) Lehratlas der MR-Mammographie. Thieme, StuttgartGoogle Scholar
  41. Fischer U, Heyden D von, Vosshenrich R, Vieweg E, Grabbe E (1993) Signalverhalten maligner und benigner Läsionen in der dynamischen 2D-MRT der Mamma. Fortschr Röntgenstr 158(4):287–292Google Scholar
  42. Fischer U, Vosshenrich R, Kopka L, Kahlen O, Grabbe E (1996 a) Kontrastmittel-gestützte dynamische MR-Mammographie nach diagnostischen und therapeutischen Eingriffen an der Mamma. Bildgebung 63:94–100PubMedGoogle Scholar
  43. Fischer U, Westerhof JP, Brinck U, Korabiowska M, Schauer A, Grabbe E (1996 b) The ductal carcinoma in situ in contrast enhanced dynamic MR mammography. RöFo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 164:290–294PubMedGoogle Scholar
  44. Fisher B, Brown A, Mamounas E, Wiand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, De Cillis A, Hoehn JL, Lees AW, Dimitrov NV (1997) Effect of preoperative chemotherapy on local-regional disease in woman with operable breast cancer findings from the National Surgical Adjuvant Breast and Bowel Project B18. J Clin Oncol 15:2483–2493PubMedGoogle Scholar
  45. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, De Cillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov NV, Bear HD (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685PubMedGoogle Scholar
  46. Fisher ER, Costantino J, Fisher B, Redmond C (1993) Pathologic findings from the national surgical adjuvant breast project (protocol 4): discriminants for 15-years survival. Cancer 71:2151–2160PubMedGoogle Scholar
  47. Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B (1978) Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42:2025–2031PubMedGoogle Scholar
  48. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ (1995) Breast MR-imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 196:143–153PubMedGoogle Scholar
  49. Fried K, Risling M, Tidcombe H, Gassmann M, Lillesaar C (2002) Expression of ErbB3, ErbB4, and neurregulin-1 mRNA during tooth development. Dev Dyn 224(3):356–360PubMedGoogle Scholar
  50. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, Contessa G (1988) Importance of tumor cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast cancer. Acta Oncol 27(5):483–487PubMedGoogle Scholar
  51. Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JF, Elston CW, Blarney RW, Ellis OE (1991) Occult regional lymph node metastases from breast carcinoma. Immunohistochemical detection with antibodies CAM 5.2 and NCRC-11. J Pathol 165(3):221–227CrossRefPubMedGoogle Scholar
  52. German Roentgen Society (1996) Recommendations for breast MRI. German Roentgen Society, Bad HomburgGoogle Scholar
  53. Gilles R, Guinebretière JM, Lucidarme O, Cluzel Ph, Janaud G, Finet JF, Tardivon A, Masselot J, Vanel D (1994) Non palpable breast tumors: diagnosis by dynamic contrast enhanced subtraction MR-imaging. Radiology 191:625–631PubMedGoogle Scholar
  54. Gilles R, Zafrani B, Guinebretière JM, Meunier M, Lucidarme O, Tardivon AA, Rochard F, Vanel D, Neuenschwander S, Arriagada R (1995) Ductal carcinoma in situ: MR-imaging-histopathologic correlation. Radiology 196:415–419PubMedGoogle Scholar
  55. Gilles R, Meunier M, Lucidarme O, Zafrani B, Guinebretière J-M, Tardivon A, Le Gal M, Vanel D, Neuenschwander S, Arriagada R (1996) Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 20(1):9–14CrossRefPubMedGoogle Scholar
  56. Giuliano AE (1996) Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 62:75–77PubMedGoogle Scholar
  57. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401PubMedGoogle Scholar
  58. Giuliano AE, Dale PS, Turner RR, Morton DKL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394–399PubMedGoogle Scholar
  59. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW (1996) Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 183:185–189PubMedGoogle Scholar
  60. Giuliano AE, Jones RC, Brentan M, Statman R (1997) Sentinel lymph node-ectomy in breast cancer. J Clin Oncol 15:2345–2350PubMedGoogle Scholar
  61. Graves TA, Bland KI (1996) Surgery for early and minimally invasive breast cancer. Curr Opin Oncol 8:468–477PubMedGoogle Scholar
  62. Greenstein-Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, Torosian MH, Rosato EF (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196:115–122PubMedGoogle Scholar
  63. Greenstein-Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC (1997) MR-imaging of ductal carcinoma in situ. Radiology 202:413–420PubMedGoogle Scholar
  64. Gribbestad I, Nilsen G, Fjone H, Kvinnsland S, Haugen O, Rinck P (1994) Comparative signal intensity measurements in dynamic gadolinium enhanced MR-mammography. J Magn Reson Imaging 4:477–480PubMedGoogle Scholar
  65. Guidi A, Fischer L, Harris J, Schmitt S (1994) Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86:614–619PubMedGoogle Scholar
  66. Gullick WJ (2001) Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor system in cancer. Breast Cancer Res 3(6):390–394 (Epub 1 Oct 2001)CrossRefPubMedGoogle Scholar
  67. Gullick WJ (2003) c-erbB-4/HER4: Friend or foe? J Pathol 200(3):279–281CrossRefPubMedGoogle Scholar
  68. Haffty BG, Ward B, Palthare P, Salem R, McKhann C, Beinfield M, Fischer D, Reiss M (1997) Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:691PubMedGoogle Scholar
  69. Hainsworth PJ, Tjandra J, Stillwell RG, Machet D, Henderson MA, Rennie GC et al (1993) Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80(4):459–463PubMedGoogle Scholar
  70. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV (1993) MR-imaging of the breast with rotating delivery of excitation of resonance: clinical experience with pathologic correlation. Radiology 187:493–501PubMedGoogle Scholar
  71. Harris J, Lippmann M, Veronesi U, Willet W (1992) Breast cancer. N Engl J Med 327:319–328PubMedGoogle Scholar
  72. Headiuk M, Huchcroft S, Temple W, Schnurr BE (1992) Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 50:47–52PubMedGoogle Scholar
  73. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W (1989) MR-imaging of the breast with GD-DTPA: use and limitations. Radiology 171:95–103PubMedGoogle Scholar
  74. Heywang-Köbrunner SH (1994) Contrast enhanced magnetic resonance imaging of the breast. Invest Radiol 29:94–104PubMedGoogle Scholar
  75. Heywang-Köbrunner SH, Beck R (1996) Clinical application of MRI. In: Heywang-Köbrunner SH (ed) Contrast-enhanced MRI of the breast, 2nd edn. Springer, Berlin Heidelberg New York, pp 157–204Google Scholar
  76. Heywang-Köbrunner SH, Viehweg P (1994) Sensitivity of contrast enhanced MR-imaging. Magn Reson Imaging Clin N Am 2:527–538PubMedGoogle Scholar
  77. Heywang-Köbrunner SH, Bick U, Bradley WG Jr, Bone B, Casselman J, Coulthard A, Fischer U, Müller-Schimpfle M, Oellinger H, Patt R, Teubner J, Friedrich M, Newstead G, Holland R, Schauer A, Sickles EA, Tabar L, Waisman J, Wernecke KD (2001) International investigation of breast MRI: results of a multicenter study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11:531–546CrossRefPubMedGoogle Scholar
  78. Hohenberger P, Reuhl T, Markwardt J, Schlag PM (1998) „Sentinel node detection“ beim Mammacarcinom. Chirurg 69:708–716CrossRefPubMedGoogle Scholar
  79. Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP (1999) Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 6:387–397PubMedGoogle Scholar
  80. International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335(8749): 1565–1568Google Scholar
  81. Jockman JA, Dive C (1998) Apoptosis and cancer chemotherapy. Humana, Press Totowa, NJGoogle Scholar
  82. Jones R, Statman R, Cabot M, Giuliano A (1996) Technical details of sentinel lymphadenectomy to breast cancer staging. Semin Surg Oncol abs 25Google Scholar
  83. Kaiser WA, Mittelmaier O (1992) MR-Mammographie bei Risikopatientinnen. Fortschr Röntgenstr 156:576–581Google Scholar
  84. Kaiser WA, Zeitler E (1989) MR-Imaging of the breast: fast imaging sequences with and without Gd-DTPA — preliminary observation. Radiology 170:681–686PubMedGoogle Scholar
  85. Kelemen PR, Herle AJ van, Giuliano AE (1998) Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133:288–292CrossRefPubMedGoogle Scholar
  86. Kim SJ, Morris EA, Lieberman L, Ballon DJ, La Trenta LR, Hadar O, Abramson A, Dershaw DD (2001) Observer variability and applicability of BI-RADS terminology of breast MR imaging: invasive carcinomas as focal masses. Am J Roentgenol 177:551–557Google Scholar
  87. Klengel S, Hietschold V, Schreiber M, Koehler K (1994) Quantitative kontrastmitteldynamische Mamma-MRT am 0,5 T-Gerät. Röntgenpraxis 47:223–228PubMedGoogle Scholar
  88. Kling KM, Ostrzega N, Schmit P (1997) Breast conservation after induction chemotherapy for locally advanced breast cancer. Am Surg 63:861–864PubMedGoogle Scholar
  89. Roller M, Barsuk D, Zippel D, Engelberg S, Ben-Ari G, Papa MZ (1998) Sentinel lymph node involvement — a predictor for axillary node status with breast cancer — has the time come? Eur J Surg Oncol 24:166–168CrossRefPubMedGoogle Scholar
  90. Krag DN (1999) The sentinel node for staging breast cancer: current review. Breast Cancer 25:233–236Google Scholar
  91. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalisation of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–340CrossRefGoogle Scholar
  92. Krag DN, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P (1998 a) The sentinel node in breast cancer — a multicenter validation study. N Engl J Med 339:941–946CrossRefPubMedGoogle Scholar
  93. Krag DN, Ashikaga T, Harlow SP, Weaver DL (1998 b) Development of sentinel node targeting technique in breast cancer patients. Breast J 4:67–74CrossRefGoogle Scholar
  94. Krag DN, Harlow SP, Weaver DL, Ashikaga T (1998 c) Technique of selected resection of radiolabeled lymph-nodes in breast cancer patients. Semin Breast Dis 1:111–116Google Scholar
  95. Krag DN, Harlow S, Weaver D, Ashikaga T (2001) Radiolabeled sentinel node biopsy: collaborative trial with the National Cancer Institute. World J Surg 25:823–828CrossRefPubMedGoogle Scholar
  96. Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE (1998) Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 5:673–680PubMedGoogle Scholar
  97. Kuhl CK, Kreft BP, Hauswirth A, Giseke J, Elevelt A, Reiser M, Child HH (1995) MR-mammography using 0.5 T. II. Differentiation between malignant and benign lesions on MR-mammography using 0.5 T and 1.5 T. RöFo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 162:482–491PubMedGoogle Scholar
  98. Kurtz JM, Spitalier JM, Amalric R (1983) Late breast recurrence after lumpectomy and irradiation. Int J Radiat Oncol Biol Phys 9(8):1191–1194PubMedGoogle Scholar
  99. Labriola L, Salatino M, Proietti CJ, Pecci A, Coso OA, Kornblihtt AI, Charreau EH, Elizalde PV (2003) Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires function ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol Cell Biol 23(3):1095–1111CrossRefPubMedGoogle Scholar
  100. Larson D, Weinstein M, Goldberg I (1986) Edema of the arm as a function of the extent of axillary surgery in patients with stage I–II carcinoma of the breast treated with primary radiotherapy. Int Radiat Oncol Biol Phys 12:1575Google Scholar
  101. Le XF, Varela CR, Bast RC Jr (2002) Heregulin-induced apoptosis. Apoptosis 7(6):483–491CrossRefPubMedGoogle Scholar
  102. Lehman CD, Miller L, Rutter CM, Tsu M (2001) Effect of training with American college of radiology breast imaging reporting and data system lexicon on mammographic interpretation skills in developing countries. Acad Radiol 8:647–650CrossRefPubMedGoogle Scholar
  103. Liberman L, Drotman M, Morris EA, La Trenta LR, Abramson AF, Zakowski MF, Dershaw DD (2000) Imaging histologic discordance at percutaneous breast biopsy. Cancer 89:2538–2546CrossRefPubMedGoogle Scholar
  104. Liu J, Kern JA (2002) Neuergulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol 27(3):306–313PubMedGoogle Scholar
  105. Lonneux M, Borbath I, Berliere M, Kirkove C, Pauwels S (2000) The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer. Clin Positron Imaging 3:45–49CrossRefPubMedGoogle Scholar
  106. Marchetti A, Buttita F, Bertacca G, Zavaglia K, Bevilacqua G, Angelucci D, Viacava P, Naccarato A, Bonadio A, Barassi F, Felicioni L, Salvatore S, Mucilli F (2001) mRNA markers of breast cancer nodal metastases: comparison between mammoglobin and carcinoembryonic antigen in 248 patients. J Pathol 195:186–190CrossRefPubMedGoogle Scholar
  107. Mascarel I de, Binichon F, Coindre JM, Trojani M (1992) Prognostic significance of breast cancer axillary node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66(3):523–527PubMedGoogle Scholar
  108. Maunsell E, Brisson J, Deschenes L (1993) Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36:315–320PubMedGoogle Scholar
  109. Mazzeo F, Accurso A, Petrella G, Capuano S, Maurelli L, Celentano L, Squame G, Salvatore M (1986) Preoperative axillary lymphscintigraphy in breast cancer: experience with subareolar injection of 99m-Tc nanocolloid albumin. Nucl Med Commun 7:5PubMedGoogle Scholar
  110. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG (1996) Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73(1):88–95PubMedGoogle Scholar
  111. McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM (1988) The prognostic significance of lymph node metastasis after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124:21–25Google Scholar
  112. Meyer JS (1998) Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 69:212–218CrossRefPubMedGoogle Scholar
  113. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK (1998) Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39:431–435PubMedGoogle Scholar
  114. Moore MP, Kinne DW (1996) Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes. Important Adv Oncol 2:45Google Scholar
  115. Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W, Kissin MW, Taylor I (1997) Staging of symptomatic primary breast cancer with MR imaging. Am J Roentgenol 169:417–424Google Scholar
  116. Nasser IA, Lee A, Bosari S, Saganich R, Heathley G, Silverman ML (1993) Occult axillary lymph node metastases in “node-negative” breast carcinoma. Hum Pathol 24(9): 950–957CrossRefPubMedGoogle Scholar
  117. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S (1997) Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol 4:104PubMedGoogle Scholar
  118. Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, Tilbury RS (1993) Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 71:3920–3925PubMedGoogle Scholar
  119. Neville AM, Price K, Gelber RD, Goldhirsch A (1991) Axillary node micrometastases and breast cancer. Lancet 337(8749):1110CrossRefGoogle Scholar
  120. Obenauer S, Fischer U, Baum F, Dannert S, Fiizesi L, Grabbe E (2001) Stereotactic vacuum care biopsy of clustered microcalcifications classified as BI-RADS3. RöFo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 173:696–701CrossRefPubMedGoogle Scholar
  121. Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, Economou JS, Nguyen M (1998) Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 82:1704CrossRefPubMedGoogle Scholar
  122. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, Borgen PE, Cody-HS III (1998) Sentinel lymph node biopsy in breast cancer: initial experience at Memorial. J Am Coll Surg 186:423–427Google Scholar
  123. Ollila DW, Brennan MB, Giuliano AE (1998) Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer. Arch Surg 133:647–651CrossRefPubMedGoogle Scholar
  124. Orel S, Schnall M, Livolsi V, Troupin R (1994) Suspicious breast lesions: MR-Imaging with radiologic-pathologic correlation. Radiology 190:485–493PubMedGoogle Scholar
  125. Page DL, Winfield AC (1986) The dense mammogram. Am J Roentgenol 147:487–489Google Scholar
  126. Pendas S, Danway E, Giuliano R, Ku N, Cox CE, Reintgen DS (2000) Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7(1):15–20CrossRefPubMedGoogle Scholar
  127. Picoli CW, Matteucci T, Outwater EK, Siegelman ES, Mitchell DG (1995) Breast cancer diagnosis with MR-imaging: effect of clinical and mammographic findings on recommendations for biopsy. Radiology 197:(P)372Google Scholar
  128. Pierce W, Harms S, Flamig D, Griffey R, Evans W, Hagans J (1991) Three dimensional gadolinium-enhanced MR-imaging of the breast. Pulse sequence with fat suppression and magnetization transfer contrast. Radiology 181:757–763PubMedGoogle Scholar
  129. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, Diest PJ van, Teule GJ (1997) Impact of lymphoscintigraphy on sentinel node identification with technetium 99m-colloidal albumin in breast cancer. J Nucl Med 38:366–368PubMedGoogle Scholar
  130. Rauschecker HF, Sauerbrei W, Gatzemeier W, Sauer R, Schauer A, Schmoor C, Schumacher M (1998) Eight-year results of a prospective non randomized study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). Eur J Cancer 34:315–323CrossRefPubMedGoogle Scholar
  131. Raymond WA, Leong A-Y (1989) Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer. Pathology 21:11–15PubMedGoogle Scholar
  132. Reuhl T, Haensch W, Markwardt J, Schlag PM (1998) Die Sentinel Lymphknoten-Detektion bei Patienten mit Mammacarcinom (Sentinel lymph node detection in patients with breast carcinoma). Zentralbl Chir 123[Suppl]5:72–74Google Scholar
  133. Rieber A, Merkle E, Böhm W, Brambs H-J, Tomczak R (1997 a) MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21(5):773–779CrossRefPubMedGoogle Scholar
  134. Rieber A, Merkle E, Zeitler H, Görich J, Kreienberg R, Brambs H-J, Tomczak R (1997 b) Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr 21(5):780–784CrossRefPubMedGoogle Scholar
  135. Roumen RM, Valkenburg JG, Genskens LM (1997) Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23:495CrossRefPubMedGoogle Scholar
  136. Sandrucci S, Mussa A (1998) Sentinel lymph node biopsy and axillary staging of T1-T2N0 breast cancer: a multicenter study. Semin Surg Oncol 15:278–283CrossRefPubMedGoogle Scholar
  137. Schauer A (1981) Pathologische Anatomie des Mammacarcinoms. In: Siewert A, Schauer A, Nagel G, Frischkorn R (eds) Mammacarcinom. Chirurgie der Gegenwart. Urban & Schwarzenberg, Munich, pp 6–39Google Scholar
  138. Schauer A, Marx D, Schauer M, Binder C, Kuhn W, Meden H (1998) Breast-preserving surgery: decision making. Anticancer Res 18:2107–2138PubMedGoogle Scholar
  139. Schauer A, Osborn M, Weber K, Altmannsberger M (1984) Antibodies to different intermediate filaments as histogenetic tumor markers. Acta Histochem Suppl 29:129–136PubMedGoogle Scholar
  140. Schauer A, Korabiowska M, Kellner S, Schumacher M, Sauer R, Bojar H, Rauschecker H (1998 a) Grading system for breast cancer. Anticancer Research 18(3C):2139–2144PubMedGoogle Scholar
  141. Schauer A, Marx D, Schauer M, Binder C, Kuhn W, Meden H (1998 b) Breast preserving surgery decision making. Anticancer Res 18(3C):2107–2137PubMedGoogle Scholar
  142. Schelfhout VR, Coene ED, Delaey B, Waeytens AA, De Rycke L, Dele M, De Potter CR (2002) The role of heregulin-alpha as a motility factor and amphiregulin as a growth factor in wound healing. J Pathol 198(4):523–533CrossRefPubMedGoogle Scholar
  143. Schreiber RH, Pendas S, Ku NN, Reintgen DS, Shons AR, Berman C, Boulware D, Cox CE (1999) Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node (see comments). Ann Surg Oncol 6:95–101CrossRefPubMedGoogle Scholar
  144. Schwartz GF, Birchansky CA, Komarnieky LT, Mansfield CM, Cantor RI, Biermann WA, Fellin FM, McFarlane J (1994) Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73:362–369PubMedGoogle Scholar
  145. Sedmak DD, Meineke T, Knechtges DS (1989) Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Arch Pathol Lab Med 113:786–789PubMedGoogle Scholar
  146. Silverberg E, Lubera J (1987) Cancer statistics. CA Cancer J Clin 37:2–19PubMedGoogle Scholar
  147. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gomagani P (1994) Axillary lymph node dissection for T1a breast carcinoma. Cancer 73:664–667Google Scholar
  148. Singer E, Landgraf R, Horan T, Slamon D, Eisenberg D (2001) Identification of a heregulin binding site in HER3 extracellular domain. J Biol Chem 23, 276(47):44266–44274 (Epub 2001)CrossRefPubMedGoogle Scholar
  149. Sloane JP, Ormerod M, Imrie SF, Coonbes RC (1980) The use of antisera to epithelial membrane antigen in detecting micrometastasis in histological sections. Br J Cancer 42(3):392–398PubMedGoogle Scholar
  150. Smith IC, Ogston KN, Whitford P, Smith FW, Sharp P, Norton M, Miller ID, Ah-See AK, Heys SD, Jibril JA, Eremin O (1998) Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluor-2-deoxy-D-glucose. Ann Surg 228:220–227CrossRefPubMedGoogle Scholar
  151. Soderstrom CE, Harms SE, Copit DS, Evans WP, Savino DA, Krakos PA, Farell RS, Feamig DP (1996) Three dimensional RODEO breast MR-imaging of lesions containing ductal carcinoma in situ. Radiology 201:427–431PubMedGoogle Scholar
  152. Springall RJ, Rytina E, Millis RR (1990) Incidence and significance of micrometastases in axillary lymph-nodes detected by immunohistochemical techniques. J Pathol 160:174AGoogle Scholar
  153. Statman R, Giuliano AE (1996) The role of the sentinel lymph node in the management of patients with breast cancer. Adv Surg 30:209–221PubMedGoogle Scholar
  154. Stamper P, Margolin F (1994) Ductal carcinoma in situ: the mammographer's perspective. Am J Roentgenol 162:585–591Google Scholar
  155. Stamper PC, Hermans S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE (1995) Suspect breast lesions: findings at dynamic gadolinium enhanced MR-imaging correlated with mammographic and pathologic features. Radiology 197:387–395PubMedGoogle Scholar
  156. Tesoro-Tess JD, Amusoro A, Rovini D, Balzarini L, Ceglia E, Civelli E, Trecate G, Savio T, Musumeci R (1995) Microcalcifications in clinically normal breasts: the value of high field surface coil Gd-DTPA-enhanced MRI. Eur Radiol 5:417–422CrossRefGoogle Scholar
  157. Turkat T, Klein B, Polan R, Richman R (1994) Dynamic MR-mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 4:563–568PubMedGoogle Scholar
  158. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271–276, 276–278CrossRefPubMedGoogle Scholar
  159. Turner RR, Ollila DW, Stern S, Giuliano EA (1999) Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263–267CrossRefPubMedGoogle Scholar
  160. Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, Delle Donne V, De Lellis R, Piotti P, Sacchini V, Conti R, Clemente C (1983) Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681PubMedGoogle Scholar
  161. Veronesi U, Cascinelli N, Greco M, Bufalino R, Clemente C, Galluzzo D, Donne V delle, Lellis R de, Sacchini V (1985) Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202:702PubMedGoogle Scholar
  162. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867CrossRefPubMedGoogle Scholar
  163. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Saccini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 17(91):368–373CrossRefGoogle Scholar
  164. Veronesi U, Zurrida S, Mazzarol G, Viale G (2001) Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 25(6):806–808CrossRefPubMedGoogle Scholar
  165. Viehweg P, Lampe D, Buchmann J, Heywang-Köbrunner SH (2000) In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 11(3):129–137PubMedGoogle Scholar
  166. Vlastos G, Rubio IT, Mirza NQ, Newman LA, Aurora R, Alderfer J, Buzdar AU, Singletary SE (2000) Impact of multicentricity on clinical outcome in patients with T1-2 N0-1 M0 breast cancer. Ann Surg Oncol 7:581–587PubMedGoogle Scholar
  167. Wahl RL, Cody RL, Hutchins GD, Mudgett EE (1991) Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179:765–770PubMedGoogle Scholar
  168. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M (2000) Pathologic analysis of sentinel and nonsentinel lymph-nodes in breast carcinoma. Cancer 88:1099–1107CrossRefPubMedGoogle Scholar
  169. Wedegartner U, Otto U, Buitrago-Tellez C, Bremerich J, Oertli D, Torhorst J, Bongartz G (2001) Percutaneous stereotactic biopsy of non-palpable breast lesions using the Advanced Breast Biopsy Instrumentation (ABBI) system: critical evaluation of indication strategies. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 173:224–228CrossRefPubMedGoogle Scholar
  170. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1–8Google Scholar
  171. Weidner N, Semple J, Welch W, Folkman J (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 84:1875–1887PubMedGoogle Scholar
  172. Weinreb JC, Newstead G (1995) MR-imaging of the breast. Radiology 196:593–610PubMedGoogle Scholar
  173. Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY (1984) The immunohistochemical detection of axillary micrometastases in breast cancer. Br J Cancer 50(2):193–19PubMedGoogle Scholar
  174. Westerhof JP, Fischer U, Moritz JD, Oestmann JW (1998) MR-imaging of mammographically detected clustered microcalcifications: is there any value? Radiology 207: 675–681PubMedGoogle Scholar
  175. Witt A, Obwegeser R, Auerbach I, Tempfer C, Yavuz D, Kubista E (2002) Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Wien Klin Wochenschr 114(10/11):387–390PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations